“…Compared with eccentric hypertrophy, the presence of concentric LV hypertrophy in hypertensive patients poses the highest risk of CVD events and mortality (12). Besides hypertension, neurohormonal agents, angiotensin II, norepinephrine, aldosterone, insulin, and other growth factors play roles in the development and promotion of LV hypertrophy (13).…”